Breath Biopsy® Microbiome Panel Webinar

Explore the latest tools for gut microbiome research with Owlstone Medical's webinar.

Watch this webinar ‘Introducing the Breath Biopsy® Microbiome Panel: using breath as a non-invasive tool to study the microbiome’ on demand. Hosted by Owlstone Medical’s Principal Translational Scientist, Dr. Nabeetha Nagalingam and VP of Business Development, Research Products and Services, Dr. Huw Davies. Hear from Dr Matt Kerr and Dr Rui Lopes during the Q&A session.

Complete the form at the end of the page to view the webinar.

Join us as we introduce the Breath Biopsy® Microbiome Panel, a non-invasive tool for studying gut microbiome activity through exhaled breath.

Ideal for researchers investigating known microbiome metabolites or exploring new health and disease links, this webinar will explore how breath anaylsis offers unique advantages including:

  • Analyse system-wide microbial metabolites absorbed in the blood stream
  • Enables real-time monitoring of metabolites produced during digestion and fermentation
  • Improved subject recruitment and retention due to the non-invasive nature of sample collection

Learn more about our speakers

Huw Davies

Dr Huw Davies

Dr Huw Davies has over 30 years experience working with novel technologies that enable the diagnosis and treatment of major human diseases.  In his current role, Huw leads a global commercial team responsible for growing Owlstone Medical’s Breath Biopsy® collaborations and service business with leading pharmaceutical companies and academic partners to identify and deploy novel non-invasive breath biomarkers for precision medicine and disease diagnosis.

Dr Nabeetha Nagalingam

Dr. Nabeetha Nagalingam is a Principal Translational Scientist with over a decade of experience in microbiome research, biomarker discovery, and test development.

Based at Owlstone Medical in Cambridge, UK, she provides scientific leadership on gut health, infectious diseases and microbiome initiatives, driving innovation across early-stage research and external collaborations. She offers insight and technical expertise in the design, execution, and evaluation of translational research and biomarker development programs.